P01 Administrative Core
P01 行政核心
基本信息
- 批准号:10226284
- 负责人:
- 金额:$ 15.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountabilityAddressAdvisory CommitteesAgricultureAntibiotic ResistanceAntibioticsAntimicrobial ResistanceBenchmarkingBudgetsClinicalClinical DataClostridium difficileCollaborationsCombating Antibiotic Resistant BacteriaCommunicationCritical IllnessDataDecision MakingDevelopmentDiagnosticDisease ProgressionDisputesEffectivenessEnsureEnterobacteriaceaeExtended-spectrum β-lactamaseGenomicsGoalsGovernmentHomeHuman ResourcesImmunocompromised HostIndustrializationInfectionIntensive Care UnitsLeadershipLifeLiquid substanceLogisticsMediatingMedicalMedical centerMinorModern MedicineMonitorOnline SystemsOperations ResearchOrganismPathogenicityPatientsPersonsPhenotypePositioning AttributeProcessProductivityProgram ReviewsProgress ReportsProteomicsPublic HealthQuality ControlRegimenResearchResearch ActivityResearch PersonnelResearch Project GrantsResolutionSamplingSystemTechniquesTexasTherapeuticTranslatingUnited NationsUnited States National Institutes of HealthVancomycin resistant enterococcusWorkcarbapenemaseclinical practicecommensal microbesconflict resolutiondata managementdata sharingfunctional genomicsgastrointestinalgut colonizationgut microbiotahigh riskimproved outcomeinsightmeetingsmetabolomicsmicrobiotamicroorganismmortalitymulti-drug resistant pathogennoveloutcome predictionpathogenprogramssample collectionsuccesssynergismtreatment strategy
项目摘要
ABSTRACT (Administrative Core)
The clinical introduction of antibiotics in 1930s-40s represented a major medical breakthrough enabling many
advances in modern medicine, agriculture and industrial practice. Unfortunately, the rise of antibiotic-resistant
microorganisms globally is now considered one of the most challenging public health threats of the 21st century.
The call for action against the threat of antibiotic resistance has now reached the highest level of government
including the Office of the US President (with the creation of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria) and the initiative for global action by the United Nations, among others.
Vancomycin-resistant enterococci (VRE), Enterobacteriaceae carrying extended spectrum β-lactamases and
carbapenemases (ESBL-E/CRE), and Clostridiodes difficile are particularly concerning for high-risk patients
who are immunocompromised and/or admitted to intensive care units (ICUs). Having the potential to cause life-
threatening infections, particularly in those patients who have already been subjected to multiple antibiotic
regimens, each of these organisms colonize the intestines, and their presence impacts subsequent colonization
by other pathogens further contributing to serious disease progression and even mortality in these high-risk
patients. Although these pathogens have been studied in isolation, elucidation of the dynamic interactions
between pathogens and commensal gut microbiota and their implication for predicting outcomes and,
thus, treatment strategies is more urgent than ever and requires a strategic, coordinated effort. The Texas
Medical Center in Houston, Texas is home to several world leaders in antimicrobial resistance research and
clinical practice with patient access and tremendous expertise in the cutting-edge genomic and phenotypic
techniques who are uniquely positioned to perform concerted and synergistic systems-level studies of the
multiple players that must be understood to address this challenge. These experts have recognized this
exceptional opportunity and the strength of addressing the critical and unmet challenge through the formation of
a multi-institutional collaborative research program Dynamics of Colonization and Infection by Multidrug-
Resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE). Crucial for the
effectiveness of this multi-institutional research effort, is dedicated centralized administrative oversight and
support. The Administrative Core will serve as the central “hub” for program oversight, accountability,
communication, and project/process coordination for the three Projects and the Functional Genomics Core. To
achieve these goals, the Administrative Core will provide integrative accountability and oversight through the
Executive Leadership Team and the Internal and External Advisory Committees, and administrative support for
all project leaders, research personnel, key collaborators and advisors, and institutional administrative liaisons.
摘要(行政核心)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cesar Augusto Arias其他文献
Cesar Augusto Arias的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cesar Augusto Arias', 18)}}的其他基金
Clinical Impact of the Cefazolin Inoculum Effect
头孢唑啉接种效果的临床影响
- 批准号:
10735541 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
The LiaFSR system and antimicrobial peptide resistance in enterococci
LiaFSR 系统和肠球菌抗菌肽耐药性
- 批准号:
10553808 - 财政年份:2022
- 资助金额:
$ 15.6万 - 项目类别:
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)
免疫功能低下和危重患者中多重耐药病原体定植和感染的动态 (DYNAMITE)
- 批准号:
10226283 - 财政年份:2020
- 资助金额:
$ 15.6万 - 项目类别:
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)
免疫功能低下和危重患者中多重耐药病原体定植和感染的动态 (DYNAMITE)
- 批准号:
10614690 - 财政年份:2020
- 资助金额:
$ 15.6万 - 项目类别:
VENOUS: A translational study of enterococcal bacteremia
静脉:肠球菌菌血症的转化研究
- 批准号:
10624439 - 财政年份:2020
- 资助金额:
$ 15.6万 - 项目类别:
Project 1: Genomics of Pathobionts and Transition From Colonization to Infection
项目 1:病原体基因组学和从定植到感染的转变
- 批准号:
10226287 - 财政年份:2020
- 资助金额:
$ 15.6万 - 项目类别:
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)
免疫功能低下和危重患者中多重耐药病原体定植和感染的动态 (DYNAMITE)
- 批准号:
10024956 - 财政年份:2020
- 资助金额:
$ 15.6万 - 项目类别:
VENOUS: A translational study of enterococcal bacteremia
静脉:肠球菌菌血症的转化研究
- 批准号:
10593508 - 财政年份:2020
- 资助金额:
$ 15.6万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant